Proteome Sciences plc (FRA:PI2)

Market Cap	6.76M -4.6%
Revenue (ttm)	4.38M -16.7%
Net Income	-2.69M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,300
Open	0.0025
Previous Close	0.0025
Day's Range	0.0025 - 0.0030
52-Week Range	0.0015 - 0.0270
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 24, 2026

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling p...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 32
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PI2

Financial Performance

In 2025, Proteome Sciences's revenue was 3.76 million, a decrease of -23.14% compared to the previous year's 4.89 million. Losses were -3.06 million, -10.13% less than in 2024.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error